| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2768873 | Revista Española de Anestesiología y Reanimación | 2011 | 6 Pages |
Abstract
Insufficient evidence is available to support the use of the triple-H therapy, clazosentan, statins, or magnesium sulfate for the prevention of cerebral vasospasm following subarachnoid hemorrhage. Nimodipine is the only preventative treatment that can be recommended.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
O. Romero Kräuchi, A.M. Verger Bennasar,